{"id":"W2165254737","doi":"10.1200/jco.2008.18.0612","title":"Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; University of California, Los Angeles; Genentech; American Society of Clinical Oncology; Bristol-Myers Squibb","keywords":"Medicine; Erlotinib; Temozolomide; Internal medicine; Oncology; Clinical endpoint; Radiation therapy; PTEN; Rash; Epidermal growth factor receptor; Cancer; EGFR inhibitors; Clinical trial; PI3K/AKT/mTOR pathway","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004003197,0.001863871,0.003391964,0.0007772323,0.0006616063,0.00103603,0.001612242,0.001410609,0.004569733],"category_scores_gemma":[0.001158135,0.0008326838,0.001736684,0.0008774519,0.001654468,0.0008395184,0.0006876031,0.002539048,0.00142827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002682144,"about_ca_system_score_gemma":0.00627986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007663901,"about_ca_topic_score_gemma":0.02665655,"domain_scores_codex":[0.9988334,0.0007182209,0.00004715356,0.0001564592,0.000101507,0.0001433119],"domain_scores_gemma":[0.9985789,0.0001537517,0.0002963093,0.00008631254,0.0001598658,0.0007248172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9060953,0.02280257,0.007557392,0.0007979971,0.001833024,0.0002067439,0.0002521508,0.000950317,0.008626501,0.0001769891,0.006041306,0.04465961],"study_design_scores_gemma":[0.8604698,0.1218795,0.01310728,0.00006715956,0.0005188227,0.0002801183,0.00007541892,0.0004861915,0.0006069894,0.00009227882,0.002391192,0.00002530435],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896007,0.003515875,0.0002556904,0.0006694424,0.0001781475,0.002886802,0.0009462171,0.00008586916,0.001861188],"genre_scores_gemma":[0.9701546,0.004508248,0.002567145,0.002334858,0.0004740544,0.006658884,0.006732374,0.00009084557,0.006478867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007663901,"threshold_uncertainty_score":0.02117115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09951748353643922,"score_gpt":0.439709968423072,"score_spread":0.3401924848866328,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}